Icon (ICLR) Equity Income (2020 - 2025)
Icon's (ICLR) quarterly Equity Income came in at $149.2 million in Q4 2025, down 49.38% year-over-year from $294.7 million in Q4 2024, and down 49.38% quarter-over-quarter from $294.7 million in Q4 2024.
Analysis
Icon (ICLR) Equity Income (2020 - 2025) Analysis & Trends
Icon (ICLR) has reported Equity Income for 6 consecutive years, with $149.2 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Equity Income fell 49.38% year-over-year to $149.2 million in Q4 2025; TTM through Dec 2025 was $788.0 million, a 4.63% decrease from a year earlier, with the FY2025 full-year figure at $229.3 million, down 68.97% from the prior year.
- Equity Income was $149.2 million for Q4 2025 at Icon, down from $294.7 million in the prior quarter.
- Over five years, Equity Income peaked at $294.7 million in Q4 2024 and troughed at -$93.6 million in Q3 2021.
- A 5-year average of $119.1 million and a median of $117.9 million in 2022 frame the typical range for Equity Income.
- Across the five-year window, Equity Income tumbled 112649.4% in 2021 and soared 48839.43% in 2024, its largest moves.
- Over 5 years, Equity Income stood at -$690000.0 in 2021, then soared by 17192.46% to $117.9 million in 2022, then surged by 55.49% to $183.4 million in 2023, then soared by 60.72% to $294.7 million in 2024, then tumbled by 49.38% to $149.2 million in 2025.
- The last three Equity Income figures came in at $149.2 million (Q4 2025), $294.7 million (Q4 2024), and $197.1 million (Q3 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 17.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | - |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | - |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | - |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -4.67 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 149.19 Mn |
| Dec 31, 2024 | 294.75 Mn |
| Sep 30, 2024 | 197.13 Mn |
| Jun 30, 2024 | 146.91 Mn |
| Mar 31, 2024 | 187.44 Mn |
| Dec 31, 2023 | 183.39 Mn |
| Sep 30, 2023 | 163.67 Mn |
| Jun 30, 2023 | 115.60 Mn |
| Mar 31, 2023 | 383,000.00 |
| Dec 31, 2022 | 117.94 Mn |
| Sep 30, 2022 | 161.16 Mn |
| Jun 30, 2022 | 116.59 Mn |
| Mar 31, 2022 | 112.76 Mn |
| Dec 31, 2021 | -690,000.00 |
| Sep 30, 2021 | -93.58 Mn |
| Jun 30, 2021 | 74.37 Mn |
| Mar 31, 2021 | 97.40 Mn |
| Dec 31, 2020 | -283,000.00 |
| Sep 30, 2020 | -83,000.00 |
| Mar 31, 2020 | -321.61 Mn |